New Zealand firm to trial pig cells to treat Parkinson’s

MELBOURNE (Reuters) – A New Zealand company plans to implant pig cells in the human brain in a clinical trial to treat Parkinson’s disease and help improve movement and brain functions in patients. The clinical trials, planned for next year, would be the first using pig brain cells for potential treatment in humans. Living Cell Technologies Ltd said on Tuesday the treatment involves transplanting “support” cells from the brain of pigs that can help repair damaged nerve tissue in people with Parkinson’s. …